Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $8.51 USD
Change Today -0.0303 / -0.35%
Volume 15.8K
BIOA On Other Exchanges
Symbol
Exchange
New York
Berlin
EN Paris
As of 11:07 AM 05/6/15 All times are local (Market data is delayed by at least 15 minutes).

bioamber inc (BIOA) Snapshot

Open
$8.50
Previous Close
$8.54
Day High
$8.51
Day Low
$8.35
52 Week High
07/15/14 - $15.29
52 Week Low
10/15/14 - $7.38
Market Cap
185.8M
Average Volume 10 Days
234.3K
EPS TTM
$-2.41
Shares Outstanding
21.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for BIOAMBER INC (BIOA)

bioamber inc (BIOA) Related Bloomberg News

View More Bloomberg News

bioamber inc (BIOA) Related Businessweek News

No Related Businessweek News Found

bioamber inc (BIOA) Details

BioAmber Inc., an industrial biotechnology company, produces and sells bio-succinic acid to various chemical market customers in the United States. Its proprietary technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into chemicals that are replacements for petroleum-derived chemicals. The company’s bio-succinic acid is used in various applications, including plasticizers, polyurethanes, personal care products, resins and coatings, de-icing and coolant solutions, fine chemicals, lubricants, and food additives, as well as anti-freeze solutions, coolants solvents, water treatment chemicals, laundry tablets and bath salts, artificial leather products, and foams made with recycled polyethylene terephthalate. Its product pipeline also includes bio-succinic acid derivatives, such as 1, 4 butanediol, gamma-butyrolactone, and succinic acid based polyesters; and C6 building block chemicals comprising adipic acid, caprolactam, and hexamethylenediamine. The company sells its products directly to its customers and commercial partners, as well as indirectly through distributor in the Asia-Pacific region. It has strategic relationships with various companies, including PTTMCC Biochem Company Limited, Vinmar International Ltd., and Mitsubishi Chemical Corporation. The company was formerly known as DNP Green Technology, Inc. and changed its name to BioAmber Inc. in September 2010. BioAmber Inc. is headquartered in Montreal, Canada.

74 Employees
Last Reported Date: 03/16/15

bioamber inc (BIOA) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $480.1K
Chief Operations Officer
Total Annual Compensation: $270.8K
Executive Vice President
Total Annual Compensation: $319.3K
Chief Commercial Officer
Total Annual Compensation: $298.0K
Chief Technology Officer
Total Annual Compensation: $320.0K
Compensation as of Fiscal Year 2014.

bioamber inc (BIOA) Key Developments

Bayer MaterialScience Selects BioAmber as Supplier for New Product Line

BioAmber Inc. has been chosen by Bayer MaterialScience as the supplier of bio-succinic acid used to produce a new range of innovative, bio-based polyurethanes for textile applications that Bayer MaterialScience has begun commercializing. Bayer MaterialScience has launched IMPRANIL® eco, a series of bio-based waterborne polyurethane dispersions with renewable content that reaches as high as 65%. IMPRANIL® eco has been developed to address the textile needs of the sportswear/footwear, automotive and fashion industries. IMPRANIL® eco enables manufacturers to produce synthetic materials and coated fabrics with a high content of renewable materials in every layer, with performance that matches the high level of conventional products, and the bio-based raw materials can be used without reformulation.

BioAmber Inc. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Year Ended December 31, 2014

BioAmber Inc. announced unaudited consolidated earnings results for the fourth quarter and year ended December 31, 2014. Revenues for the year ended December 31, 2014 decreased to $1.5 million from $2.7 million for the same period in 2013. Sales volume in 2014 was slightly higher than in 2013, but was offset by a decrease in the average sales price that resulted from customers seeking pricing more in line with the prices BioAmber has contractually committed to for future Sarnia supply. The company continues to manage sales in an effort to preserve its bio-succinic acid inventory levels in advance of the Sarnia plant start-up. The company recorded a net loss attributable to BioAmber Inc. shareholders of $46.4 million, or a loss of $2.32 per share, for the year ended December 31, 2014, as compared to a net loss of $33.2 million, or a loss of $2.13 per share, for the same period in 2013. The adjusted net loss attributable to BioAmber Inc. Shareholders for the year ended December 31, 2014 was $34.7 million, or a loss of $1.74 per share, compared to an adjusted net loss attributable to BioAmber Inc. Shareholders of $33.6 million, or a loss of $2.16 per share, for the same period in 2013. Operating loss was $35.205 million against $41.180 million a year ago. Net cash used in operating activities was $22.453 million against $27.525 million a year ago. Acquisition of property and equipment was $85.014 million against $12.788 million a year ago. Loss before income taxes was $47.222 million against $33.688 million a year ago. For the quarter, the company reported product sales of $0.308 million, operating loss of $9.038 million and net loss attributable to shareholders of $4.357 million or $0.20 per basic share compared to product sales of $0.439 million, operating loss of $7.810 million and net loss attributable to shareholders of $7.828 million or $0.42 per basic share a year ago period. Net cash used in operating activities was $12.247 million against $4.815 million a year ago. Acquisition of property and equipment was $25.540 million against $8.181 million a year ago. Adjusted Net Loss attributable to company shareholders was $10,378 million or $0.48 per basic share against $8.388 million or $0.45 per basic share a year ago. Loss before income taxes was $4.710 million against $7.950 million a year ago.

BioAmber Inc. to Report Q4, 2014 Results on Mar 12, 2015

BioAmber Inc. announced that they will report Q4, 2014 results at 4:30 PM, US Eastern Standard Time on Mar 12, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIOA:US $8.51 USD -0.0303

BIOA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BIOA.
View Industry Companies
 

Industry Analysis

BIOA

Industry Average

Valuation BIOA Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOAMBER INC, please visit www.bio-amber.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.